unc119b Antibody

Basic Research Questions

• What is UNC119B and how does it differ from UNC119A?

  UNC119B is a paralog of UNC119A, both functioning as guanine dissociation inhibitor-like solubilizing factors (GSFs) that share a beta sandwich immunoglobulin fold. This structural feature forms a hydrophobic pocket that can accommodate and sequester lipid modifications, particularly N-myristoylated proteins . Despite high sequence similarity, UNC119B and UNC119A exhibit significant functional differences:

  Feature	UNC119B	UNC119A
  Molecular Weight	28-31 kDa	27 kDa
  Unique Structure	Contains a stretch of negatively charged amino acids	Lacks the negatively charged region found in UNC119B
  Cargo Binding	Variable affinity for high-affinity cargo peptides (up to 427-fold variation)	More consistent binding to high-affinity cargo (only 16-fold variation)
  Release Mechanism	Generally more efficient cargo release	Less efficient cargo release for equivalent cargo

• What applications are validated for UNC119B antibodies?

  UNC119B antibodies have been validated for multiple research applications as demonstrated by various studies :

  Application	Validated Dilution Range	Sample Types
  Western Blot (WB)	1:1000-1:6000	A549 cells, MDCK cells, mouse kidney tissue, HEK-293 cells, HeLa cells
  Immunofluorescence (IF)/ICC	1:50-1:500	MDCK cells
  ELISA	Validation confirmed	Human, mouse, canine samples

  Methodological approach: For optimal results, titrate the antibody in your specific testing system, as reactivity may depend on sample type and experimental conditions .

• What is the molecular function of UNC119B in protein trafficking?

  UNC119B functions as a cargo adapter by specifically binding the myristoyl moiety of N-terminally myristoylated proteins, which is essential for their proper localization . The molecular mechanism involves:

  • Formation of a hydrophobic pocket that masks the lipid modification from the hydrophilic cytosol

  • Trafficking of cargo proteins between different membranes

  • Release of cargo proteins through interaction with Arf-like proteins (ARL2 and ARL3)

  • Differential release patterns: high-affinity cargoes (e.g., NPHP3, Cystin1) are specifically released by ARL3·GTP, while low-affinity cargoes can be released by both ARL2·GTP and ARL3·GTP

  This process is crucial for ciliary protein localization, as demonstrated by UNC119B's role in localizing NPHP3 to the primary cilium .

Intermediate Research Questions

• How should I optimize Western blot conditions for UNC119B detection?

  For optimal Western blot detection of UNC119B:

  1. Sample preparation: Use established cell lines with confirmed UNC119B expression (A549, MDCK, HEK-293, HeLa)

  2. Loading control: Include appropriate loading controls such as GAPDH, vinculin, or LCK

  3. Antibody dilution: Begin with a 1:1000 dilution and optimize through titration (1:1000-1:6000)

  4. Expected band size: Look for bands at 28-31 kDa

  5. Validation strategy: Consider using both positive controls (cells with known UNC119B expression) and negative controls (such as UNC119B-depleted samples)

  For problematic detection, try reducing the antibody concentration, optimizing blocking conditions, or using alternative detection methods such as chemiluminescence or fluorescence-based systems.

• What are the binding characteristics of UNC119B to different myristoylated cargo peptides?

  UNC119B exhibits variable binding affinities to different N-myristoylated peptides, which affects cargo trafficking and release mechanisms:

  Cargo Peptide	Binding Affinity to UNC119B	Comparison to UNC119A	Release Characteristics
  NPHP3	0.17 nM	Higher affinity than UNC119A (0.84 nM)	Only released by ARL3·GTP
  LCK	0.37 nM	Higher affinity than UNC119A (0.83 nM)	More efficiently released from UNC119B despite higher affinity
  FMNL1	Lower affinity than UNC119A (9.5-fold difference)	Higher affinity binding	More efficiently released from UNC119B
  PCMTD1	Lower affinity than UNC119A (13.8-fold difference)	Higher affinity binding	More efficiently released from UNC119B
  GNAT1	Higher affinity for UNC119A (>10-fold difference)	Higher affinity binding	Partially released by ARL2·GTP when bound to UNC119B but not UNC119A

  Methodological approach: To determine binding affinities experimentally, use fluorescence polarization assays with fluorescently labeled myristoylated peptides and titrate purified UNC119B protein .

• How can I use immunofluorescence to study UNC119B localization during cell signaling events?

  For studying UNC119B localization during signaling events:

  1. Sample preparation:

     • For T-cell activation studies: Form immune conjugates between T cells and antigen-presenting cells

     • For ciliary localization: Use ciliated cells like MDCK

  2. Immunostaining protocol:

     • Fix cells in 1% paraformaldehyde

     • Permeabilize with appropriate detergent (0.1% Triton X-100 or 0.1% saponin)

     • Block with 5% normal serum

     • Incubate with UNC119B antibody at 1:50-1:500 dilution

     • Use appropriate fluorescent secondary antibodies

  3. Visualization markers:

     • Co-stain with markers for specific cellular compartments (F-actin for cell borders, CD3 for TCR complex)

     • For translocation experiments: Use GFP-tagged UNC119B and stimulate with antibody-coated beads

  4. Analysis approach:

     • Examine 50-70 cells per experiment across three independent experiments

     • Quantify translocation by measuring fluorescence intensity at regions of interest

     • Calculate membrane-to-cytosol redistribution by subtracting intensity at cell border from whole cell

Advanced Research Questions

• What structural features contribute to the unique cargo release mechanisms of UNC119B compared to UNC119A?

  The crystal structures of UNC119B reveal several key features that contribute to its unique cargo release mechanism:

  1. Negatively charged amino acid stretch: UNC119B contains a unique region of negatively charged residues that may undergo conformational changes following binding to release factors

  2. Cargo binding pocket:

     • The hydrophobic pocket accommodates the myristoyl moiety of cargo proteins

     • Crystal structure of UNC119B-LCK peptide complex shows how UNC119B forms additional interactions with the LCK peptide not observed in UNC119A

  3. ARL3 interaction interface:

     • The interaction between UNC119B and ARL3 occurs primarily through a parallel β-strand interaction between switch I of ARL3 and a β-strand on UNC119B

     • Additional electrostatic interactions involve UNC119B K99 with ARL3 E40 and UNC119B R101 with ARL3 S39

     • The ARL3 binding residues of UNC119B are highly conserved compared to UNC119A, with only two residue differences (R198 in UNC119B is K in UNC119A; D206 in UNC119B is E in UNC119A)

  These structural differences may explain why certain cargo peptides are more efficiently released from UNC119B despite having higher binding affinities .

• How can I experimentally distinguish between ARL2 and ARL3-mediated cargo release from UNC119B?

  To experimentally distinguish between ARL2 and ARL3-mediated cargo release from UNC119B:

  1. Experimental setup:

     • Prepare complexes of UNC119B bound to different myristoylated peptides (high-affinity vs. low-affinity cargoes)

     • Use fluorescence polarization assays with 100 nM fluorescently labeled peptide, 200 nM UNC119B, and 2 μM ARL2/3

     • Measure changes in polarization upon addition of ARL2·GTP vs. ARL3·GTP

  2. Expected outcomes:

     • High-affinity cargoes (NPHP3, Cystin1): Should be released only by ARL3·GTP, not ARL2·GTP

     • Intermediate-affinity cargoes (GNAT1): May show partial release by ARL2·GTP when bound to UNC119B but not UNC119A

     • Low-affinity cargoes (Src, RP2): Should be released by both ARL2·GTP and ARL3·GTP

  3. Control experiments:

     • Use cargo-binding mutants of UNC119B to confirm specificity

     • Include nucleotide-free ARL proteins as negative controls

  4. Analysis approach:

     • Calculate release efficiency by comparing polarization values before and after addition of ARL proteins

     • Correlate release efficiency with measured binding affinities for each cargo peptide

• What methodologies can be used to study the role of UNC119B in T-cell receptor signaling?

  To investigate UNC119B's role in T-cell receptor signaling:

  1. Protein-protein interaction studies:

     • Co-immunoprecipitation to detect association with CD3 and CD4 molecules

     • GST-UNC119B pulldown experiments to identify interacting partners

     • Analyze recruitment to receptors before and after anti-CD3 stimulation

  2. Subcellular localization:

     • Express GFP-UNC119B in T cells and track translocation upon TCR engagement

     • Use anti-CD3-coated beads to stimulate cells and observe UNC119B localization to contact zones

     • Perform co-capping experiments with anti-CD4 antibody

  3. Functional assays:

     • Generate UNC119B-deficient T cells and assess IL-2 production and cellular proliferation

     • Reconstitute cells with UNC119B to reverse signaling defects

     • Use UNC119 inhibitors to disrupt endogenous LCK localization and evaluate effects on T-cell signaling

  4. Single-cell analysis:

     • Use scRNAseq to analyze expression patterns of UNC119B, ARL3, and ARL13b in different T-cell populations

     • Correlate expression with T-cell activation states and memory formation

• How do single amino acid mutations in UNC119B affect its function in cargo trafficking and disease pathogenesis?

  Single amino acid mutations in UNC119 proteins can significantly impact their function with pathological consequences:

  1. V22G mutation in UNC119A:

     • Found in a patient with idiopathic CD4 lymphopenia

     • Disrupts UNC119-LCK interaction needed for TCR stimulation

     • Causes mislocalization of LCK to Rab11+ perinuclear endosomes

     • Results in reduced response to TCR stimulation and decreased cell proliferation

  2. Experimental approach to study UNC119B mutations:

     • Generate equivalent mutations in UNC119B based on sequence alignment with UNC119A

     • Express mutant proteins in cell culture and assess binding to cargo peptides

     • Analyze effects on cargo release using fluorescence polarization assays

     • Evaluate cellular phenotypes such as ciliary protein localization or T-cell activation

     • Use structure-guided mutagenesis to manipulate binding affinities between high and low

  3. Clinical relevance:

     • Mutations affecting UNC119B's interaction with ARL3 might impair ciliary protein trafficking

     • Mutations disrupting cargo binding could affect both ciliary function and T-cell signaling

     • Understanding the structure-function relationship could aid in developing therapeutic approaches for ciliopathies or immunodeficiencies

Specialized Research Applications

• How can I use UNC119B antibodies to investigate ciliary protein trafficking?

  To investigate ciliary protein trafficking using UNC119B antibodies:

  1. Experimental models:

     • Use ciliated cell lines such as MDCK cells, which have validated reactivity with UNC119B antibodies

     • Primary ciliated cells from tissues like kidney or retina

  2. Co-localization studies:

     • Perform immunofluorescence to co-localize UNC119B with ciliary markers

     • Track the localization of known UNC119B cargoes such as NPHP3 in relation to UNC119B

  3. Functional assays:

     • UNC119B knockdown or knockout using siRNA or CRISPR/Cas9

     • Rescue experiments with wild-type or mutant UNC119B

     • Assess ciliary localization of cargo proteins in the presence or absence of UNC119B

  4. Live-cell imaging:

     • Express fluorescently tagged UNC119B and cargo proteins

     • Monitor trafficking to the cilium in real-time

     • Use photoactivatable or photoconvertible fluorescent proteins to track specific protein populations

  UNC119B is required for localizing NPHP3 to the primary cilium through its myristoyl-binding activity , making it an excellent target for studying ciliary protein trafficking mechanisms.

• What biochemical approaches can determine the specificity of UNC119B antibodies versus UNC119A?

  To determine antibody specificity between UNC119B and UNC119A:

  1. Western blot analysis:

     • Run purified recombinant UNC119A and UNC119B proteins in parallel

     • Probe with the antibody of interest

     • Look for differential binding patterns based on expected molecular weights (UNC119B: 28-31 kDa ; UNC119A: 27 kDa )

  2. Immunodepletion experiments:

     • Pre-incubate the antibody with excess recombinant UNC119B

     • Test the depleted antibody on samples containing both UNC119A and UNC119B

     • Compare with non-depleted antibody to assess specific binding loss

  3. Knockout/knockdown validation:

     • Use UNC119B-specific siRNA or CRISPR/Cas9 to deplete UNC119B

     • Perform western blot or immunofluorescence to confirm loss of signal

     • Ensure UNC119A expression remains unchanged as a control

  4. Epitope mapping:

     • Use peptide arrays covering unique regions of UNC119B not present in UNC119A

     • Identify the specific epitope recognized by the antibody

     • Focus on regions with lower sequence homology between the paralogs